Xenon Pharmaceuticals to Participate in the Stifel 3rd Annual CNS Day
March 29 2021 - 4:05PM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage
biopharmaceutical company, today announced that the Company will
participate in a fireside chat at the following virtual investor
conference:
- Stifel 3rd Annual CNS Day (fireside
chat presentation) on Wednesday, March 31, 2021 at 1:00 pm ET
The presentation will be webcast live and
archived on the “Investors” section of Xenon's website at
http://investor.xenon-pharma.com.
The above listed dates and times are subject to
change.
About Xenon Pharmaceuticals
Inc.
We are a clinical stage biopharmaceutical
company committed to developing innovative therapeutics to improve
the lives of patients with neurological disorders. We are advancing
a novel product pipeline of neurology therapies to address areas of
high unmet medical need, with a focus on epilepsy. For more
information, please visit www.xenon-pharma.com.
Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Sep 2023 to Sep 2024